Phase I Dose Escalating Study of TKI258

Clinical trial NCT01471548 · COMPLETED

Trial details

NCT number: NCT01471548
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2008-09-01
Primary completion: 2012-05-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.